420 related articles for article (PubMed ID: 25643156)
21. Kisspeptin in the Hypothalamus of 2 Rat Models of Polycystic Ovary Syndrome.
Osuka S; Iwase A; Nakahara T; Kondo M; Saito A; Bayasula ; Nakamura T; Takikawa S; Goto M; Kotani T; Kikkawa F
Endocrinology; 2017 Feb; 158(2):367-377. PubMed ID: 27983870
[TBL] [Abstract][Full Text] [Related]
22. Reproductive and metabolic phenotype of a mouse model of PCOS.
van Houten EL; Kramer P; McLuskey A; Karels B; Themmen AP; Visser JA
Endocrinology; 2012 Jun; 153(6):2861-9. PubMed ID: 22334715
[TBL] [Abstract][Full Text] [Related]
23. The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome.
Mahmoud AA; Elfiky AM; Abo-Zeid FS
Steroids; 2022 Jan; 177():108936. PubMed ID: 34752810
[TBL] [Abstract][Full Text] [Related]
24. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
Ryan GE; Malik S; Mellon PL
Endocrinology; 2018 Apr; 159(4):1734-1747. PubMed ID: 29471436
[TBL] [Abstract][Full Text] [Related]
25. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model.
Venken K; De Gendt K; Boonen S; Ophoff J; Bouillon R; Swinnen JV; Verhoeven G; Vanderschueren D
J Bone Miner Res; 2006 Apr; 21(4):576-85. PubMed ID: 16598378
[TBL] [Abstract][Full Text] [Related]
26. Removal of DHT can relieve polycystic ovarian but not metabolic abnormalities in DHT-induced hyperandrogenism in mice.
Sun LF; Yang YL; Xiao TX; Li MX; Zhang JV
Reprod Fertil Dev; 2019 Sep; 31(10):1597-1606. PubMed ID: 31142430
[TBL] [Abstract][Full Text] [Related]
27. The therapeutic effect of interleukin-22 in high androgen-induced polycystic ovary syndrome.
Qi X; Yun C; Liao B; Qiao J; Pang Y
J Endocrinol; 2020 May; 245(2):281-289. PubMed ID: 32163914
[TBL] [Abstract][Full Text] [Related]
28. High level of C-type natriuretic peptide induced by hyperandrogen-mediated anovulation in polycystic ovary syndrome mice.
Wang X; Wang H; Liu W; Zhang Z; Zhang Y; Zhang W; Chen Z; Xia G; Wang C
Clin Sci (Lond); 2018 Apr; 132(7):759-776. PubMed ID: 29535265
[TBL] [Abstract][Full Text] [Related]
29. Endocrine traits of polycystic ovary syndrome in prenatally androgenized female Sprague-Dawley rats.
Wu XY; Li ZL; Wu CY; Liu YM; Lin H; Wang SH; Xiao WF
Endocr J; 2010; 57(3):201-9. PubMed ID: 20057162
[TBL] [Abstract][Full Text] [Related]
30. Apelin receptor modulation mitigates letrozole-induced polycystic ovarian pathogenesis in mice.
Anima B; Gurusubramanian G; Roy VK
Cytokine; 2024 Jul; 179():156639. PubMed ID: 38733946
[TBL] [Abstract][Full Text] [Related]
31. Androgens and polycystic ovary syndrome.
Nisenblat V; Norman RJ
Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):224-31. PubMed ID: 19390322
[TBL] [Abstract][Full Text] [Related]
32. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies.
Xita N; Tsatsoulis A
J Clin Endocrinol Metab; 2006 May; 91(5):1660-6. PubMed ID: 16522691
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Blank SK; McCartney CR; Helm KD; Marshall JC
Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen Receptor.
Feng M; Divall S; Jones D; Ubba V; Fu X; Yang L; Wang H; Yang X; Wu S
Front Endocrinol (Lausanne); 2022; 13():868572. PubMed ID: 35757434
[TBL] [Abstract][Full Text] [Related]
35. Voluntary Exercise Improves Estrous Cyclicity in Prenatally Androgenized Female Mice Despite Programming Decreased Voluntary Exercise: Implications for Polycystic Ovary Syndrome (PCOS).
Homa LD; Burger LL; Cuttitta AJ; Michele DE; Moenter SM
Endocrinology; 2015 Dec; 156(12):4618-28. PubMed ID: 26360506
[TBL] [Abstract][Full Text] [Related]
36. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.
Skrgatic L; Baldani DP; Cerne JZ; Ferk P; Gersak K
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):107-12. PubMed ID: 22107839
[TBL] [Abstract][Full Text] [Related]
37. Deletion of Androgen Receptor in LepRb Cells Improves Estrous Cycles in Prenatally Androgenized Mice.
Cara AL; Burger LL; Beekly BG; Allen SJ; Henson EL; Auchus RJ; Myers MG; Moenter SM; Elias CF
Endocrinology; 2023 Jan; 164(3):. PubMed ID: 36683455
[TBL] [Abstract][Full Text] [Related]
38. Prenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure.
Amalfi S; Velez LM; Heber MF; Vighi S; Ferreira SR; Orozco AV; Pignataro O; Motta AB
PLoS One; 2012; 7(5):e37658. PubMed ID: 22655062
[TBL] [Abstract][Full Text] [Related]
39. Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function?
van Houten EL; Visser JA
Reprod Biol; 2014 Mar; 14(1):32-43. PubMed ID: 24607253
[TBL] [Abstract][Full Text] [Related]
40. Pigment epithelium-derived factor (PEDF) negates hyperandrogenic PCOS features.
Miller I; Bar-Joseph H; Nemerovsky L; Ben-Ami I; Shalgi R
J Endocrinol; 2020 May; 245(2):291-300. PubMed ID: 32171180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
